leadf
logo-loader
viewLexaria Bioscience Corp.

Lexaria Bioscience says it supports DehydraTECHTM licensee Boldt Runners' corporate growth initiatives

Boldt Runners' Cannadips CBD is the leading CBD oral pouch brand in America, and Lexaria's fast-acting absorption technology is inside every tin

Lexaria Bioscience Corp. - Lexaria Bioscience Corp says it supports the corporate growth initiatives underway by its DehydraTECHTM licensee Boldt Runners Corporation, owners of the Cannadips CBD brand
Boldt Runners is preparing for strong growth through its recent executive appointments, financing, and sales channel expansion

Lexaria Bioscience Corp (OTCMKTS:LXRP) (CSE:LXX) said Wednesday it supports the corporate growth initiatives underway by its DehydraTECHTM licensee Boldt Runners Corporation, owners of the Cannadips CBD brand.

Cannadips CBD is the original and leading CBD oral pouch brand in America, and Lexaria said its fast-acting absorption technology is inside every tin. 

Lexaria added that Boldt Runners is preparing for strong growth through its recent executive appointments, financing, and sales channel expansion. The combination is expected to lead to a large increase in sales volumes over the next 12 months.

READ: Lexaria Bioscience strikes R&D agreement with British American Tobacco to investigate its technology for potential use in nicotine products

The company said Peter Diatelevi has been appointed as Boldt Runners' new chief executive officer. He brings more than two decades of experience with Altria Corp, leading field sales and sales operations in a number of roles including vice president of sales operations.

Also, Maura Scott has been appointed chief sales and compliance officer, and was most recently vice president of the Northeast Region and led a sales team of 400 people across 13 states for Altria Corp. And Case Mandel, former Boldt Runners CEO and co-founder, is now chairman of the board and president.

"I am excited to join the Cannadips CBD brand and am truly fortunate to be working with such an amazing team and product,” said Diatelevi in a statement.

“I have long believed that providing a viable non-tobacco and non-nicotine dip alternative for adults is an important step forward. The work Cannadips CBD has done on the development of this product is outstanding, and I look forward to working with Lexaria as we continue to develop and implement the technology."

Fostering growth in sales and manufacturing

Lexaria said Boldt Runners is fostering growth in sales and manufacturing. The company recently built a new state-of-the-art manufacturing facility in Humboldt County, California, that will allow for expanded production levels of cutting-edge pouching technologies, as well as for future growth. In addition, the licensed facility will soon include the capability of implementing Lexaria's DehydraTECH technologies into infused cannabinoid products.

Cannadips CBD plans continued expansion through its existing relationship with existing and future trade partners and with a strong e-commerce presence, will be introducing new flavors throughout these networks, including planned expansions to new states.

The Kelowna, British Columbia-based Lexaria has developed and markets DehydraTECH, which masks unwanted tastes, improves onset speed and increases the bioavailability of active pharmaceutical ingredients in a simple and cost-effective platform.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Quick facts: Lexaria Bioscience Corp.

Price: 0.33 CAD

CSE:LXX
Market: CSE
Market Cap: $29.56 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp. named herein, including the promotion by the Company of Lexaria Bioscience Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Lexaria Bioscience signs R&D agreement with British American Tobacco

Lexaria Bioscience (CSE: LXRP-OTCQX: LXRP) CEO Chris Bunka joined Steve Darling from Proactive Vancouver to share news the company has signed a deal with British American Tobacco Limited. That company has products sold in over 11 million locations across more than 180 countries. Bunka telling...

3 weeks ago

3 min read